Clinical Trials
21 trialsNCT07356037 2026-01-21
Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT02330926 2025-08-29
MENAC
Norwegian University of Science and Technology
Phase 3 Completed
NCT06517199 2024-07-24
Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Mahidol University
Phase 3 Recruiting
NCT03743051 2024-06-26
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
Phase 3 Completed
NCT03743064 2024-06-26
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
Phase 3 Completed
NCT00006799 2021-09-09
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT00031785 2021-09-09
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Wake Forest University Health Sciences
Phase 3 Completed
NCT04001010 2021-02-05
SERENITY
Tetra Bio-Pharma
Phase 3 Suspended
NCT00081250 2020-04-29
Creatine in Treating Patients With Cancer-Associated Weight Loss
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01387269 2017-10-27
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT01387282 2017-10-27
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT01395914 2017-09-14
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)
Helsinn Therapeutics (U.S.), Inc
Phase 3 Completed
NCT00053053 2016-12-08
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00040885 2016-12-07
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00031707 2016-07-14
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00637728 2016-06-23
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT00637806 2016-05-02
Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT01132547 2015-07-02
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
University of South Florida
Phase 3 Terminated
NCT01046383 2015-01-21
Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients
Immunotec Inc.
Phase 3 Terminated
NCT00513357 2012-12-11
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00046904 2011-05-05
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Mayo Clinic
Phase 3 Completed